Insider Transactions Reported by 18 Insiders of Structure Therapeutics Inc.

Symbol
GPCR on Nasdaq
Location
South San Francisco, CA

Insiders trading volume in the past year

Structure Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
FMR LLC Other*, 10%+ Owner $54,574,954 -$4,062,796 -6.9% 15 Jan 2026
Ramy Farid Director $17,176,500 07 Feb 2023
Jun Yoon Chief Financial Officer $9,088,056 15 Mar 2025
Raymond C. Stevens CHIEF EXECUTIVE OFFICER, Director $8,379,760 15 Mar 2025
Crespo Blas Coll Chief Medical Officer $1,731,574 18 Sep 2025
Xichen Lin Chief Scientific Officer $1,396,901 01 Jul 2025
Ashley Hall Chief Development Officer $869,704 18 Sep 2025
Yingli Ma Chief Technology Officer $811,531 01 Jul 2025
Melita Sun Jung Chief Business Officer $62,460 07 Feb 2023
SHARON TETLOW Director 23 Jun 2025
Angus C. Russell Director 23 Jun 2025
BVF PARTNERS L P/IL 10%+ Owner 10 May 2023
FIL Ltd Other* 07 Feb 2023
DANIEL G. WELCH Director 23 Jun 2025
Ted W Love Director 23 Jun 2025
Mark Allen Bach Chief Medical Officer 15 Mar 2024
Joanne Waldstreicher Director 23 Jun 2025
ERIC DOBMEIER Director 23 Jun 2025

Recent Insider Transactions by Companies or Individuals for Structure Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.